Jerald Z Gong

Summary

Affiliation: Duke University Medical Center
Country: USA

Publications

  1. ncbi Burkitt lymphoma arising in organ transplant recipients: a clinicopathologic study of five cases
    Jerald Z Gong
    Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA
    Am J Surg Pathol 27:818-27. 2003
  2. ncbi Posttransplant lymphoproliferative disorder after umbilical cord blood transplantation in children
    Jerald Z Gong
    Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA
    Am J Surg Pathol 30:328-36. 2006
  3. ncbi Diagnostic impact of core-needle biopsy on fine-needle aspiration of non-Hodgkin lymphoma
    Jerald Z Gong
    Department of Pathology, Duke University Medical Center, Durham, North Carolina 27710, USA
    Diagn Cytopathol 31:23-30. 2004
  4. ncbi Posttransplant lymphoproliferative disorder following nonmyeloablative allogeneic stem cell transplantation
    Matthew J Snyder
    Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA
    Am J Surg Pathol 28:794-800. 2004
  5. ncbi Clinicopathologic findings in high-grade B-cell lymphomas with typical Burkitt morphologic features but lacking the MYC translocation
    Deborah W Sevilla
    Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA
    Am J Clin Pathol 128:981-91. 2007
  6. ncbi The value of fluorescence in situ hybridization and polymerase chain reaction in the diagnosis of B-cell non-Hodgkin lymphoma by fine-needle aspiration
    Anne M Safley
    Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA
    Arch Pathol Lab Med 128:1395-403. 2004
  7. ncbi Morphologic examination of sequential bone marrow biopsies after nonmyeloablative stem cell transplantation complements molecular studies of donor engraftment
    Anand S Lagoo
    Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA
    Arch Pathol Lab Med 130:1479-88. 2006
  8. ncbi Partially matched, nonmyeloablative allogeneic transplantation: clinical outcomes and immune reconstitution
    David A Rizzieri
    Department of Medicine, Division of Cellular Therapy, Duke University Medical Center, Durham, NC 27710, USA
    J Clin Oncol 25:690-7. 2007
  9. ncbi Mediastinal adenopathy, lung infiltrates, and hemophagocytosis: unusual manifestation of pediatric anaplastic large cell lymphoma: report of two cases
    Deborah W Sevilla
    Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA
    Am J Clin Pathol 127:458-64. 2007
  10. ncbi Spectrin isoforms: differential expression in normal hematopoiesis and alterations in neoplastic bone marrow disorders
    Lucia R Wolgast
    Department of Pathology, Montefiore Medical Center, Bronx, NY 10467, USA
    Am J Clin Pathol 136:300-8. 2011

Collaborators

Detail Information

Publications17

  1. ncbi Burkitt lymphoma arising in organ transplant recipients: a clinicopathologic study of five cases
    Jerald Z Gong
    Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA
    Am J Surg Pathol 27:818-27. 2003
    ..Genotypic and phenotypic aberrations are often present. Rituximab may be an effective alternative to conventional combination chemotherapy in the treatment of a posttransplant Burkitt lymphoma...
  2. ncbi Posttransplant lymphoproliferative disorder after umbilical cord blood transplantation in children
    Jerald Z Gong
    Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA
    Am J Surg Pathol 30:328-36. 2006
    ..PTLD may be of donor or recipient origin depending on engraftment status. Both monomorphic and polymorphic histology may be seen, and monomorphic histology appears to predict an unfavorable prognosis...
  3. ncbi Diagnostic impact of core-needle biopsy on fine-needle aspiration of non-Hodgkin lymphoma
    Jerald Z Gong
    Department of Pathology, Duke University Medical Center, Durham, North Carolina 27710, USA
    Diagn Cytopathol 31:23-30. 2004
    ..Cases insufficient for diagnosis may be seen in both core-needle biopsy and FNA. A combined approach reduces the number of insufficient cases and is recommended in routine FNA practice...
  4. ncbi Posttransplant lymphoproliferative disorder following nonmyeloablative allogeneic stem cell transplantation
    Matthew J Snyder
    Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA
    Am J Surg Pathol 28:794-800. 2004
    ..All three PTLDs arose 6 to 7 months after NMST and were rapidly fatal. The pathology of the PTLD in all cases was donor origin, EBV positive, diffuse large B-cell lymphoma...
  5. ncbi Clinicopathologic findings in high-grade B-cell lymphomas with typical Burkitt morphologic features but lacking the MYC translocation
    Deborah W Sevilla
    Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA
    Am J Clin Pathol 128:981-91. 2007
    ..Provisional identification of MYC- lymphomas with typical Burkitt morphologic features as an entity separate from DLBCL will facilitate further studies and possible categorization as a separate entity...
  6. ncbi The value of fluorescence in situ hybridization and polymerase chain reaction in the diagnosis of B-cell non-Hodgkin lymphoma by fine-needle aspiration
    Anne M Safley
    Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA
    Arch Pathol Lab Med 128:1395-403. 2004
    ..By incorporating FISH and PCR methods, FNA may assume an expanded role for the primary diagnosis of B-cell non-Hodgkin lymphoma...
  7. ncbi Morphologic examination of sequential bone marrow biopsies after nonmyeloablative stem cell transplantation complements molecular studies of donor engraftment
    Anand S Lagoo
    Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA
    Arch Pathol Lab Med 130:1479-88. 2006
    ..Nonmyeloablative stem cell transplantation (NMSCT) is a mode of immunotherapy increasingly employed in treating hematologic, lymphoid, and solid tumors. Patients are monitored principally by molecular analysis of donor engraftment...
  8. ncbi Partially matched, nonmyeloablative allogeneic transplantation: clinical outcomes and immune reconstitution
    David A Rizzieri
    Department of Medicine, Division of Cellular Therapy, Duke University Medical Center, Durham, NC 27710, USA
    J Clin Oncol 25:690-7. 2007
    ..To allow a donor to be found for nearly all patients, we have used a nonmyeloablative conditioning regimen in conjunction with stem cells from a related donor with one fully mismatched HLA haplotype...
  9. ncbi Mediastinal adenopathy, lung infiltrates, and hemophagocytosis: unusual manifestation of pediatric anaplastic large cell lymphoma: report of two cases
    Deborah W Sevilla
    Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA
    Am J Clin Pathol 127:458-64. 2007
    ..These findings are similar to the first reported case and indicate that pediatric ALCL can manifest with an unusual constellation of symptoms consisting of hemophagocytosis, mediastinal or hilar adenopathy, and lung infiltrates...
  10. ncbi Spectrin isoforms: differential expression in normal hematopoiesis and alterations in neoplastic bone marrow disorders
    Lucia R Wolgast
    Department of Pathology, Montefiore Medical Center, Bronx, NY 10467, USA
    Am J Clin Pathol 136:300-8. 2011
    ..0398; Fisher exact test) and 5 (100%) of 5 EryLs expressed βII spectrin but lacked βI spectrin. The frequent loss and/or gain of spectrin isoforms in AMLs suggests a possible role for spectrin in leukemogenesis...
  11. ncbi Rituximab in lymphocyte predominance Hodgkin's disease: a case series
    Valerie K Ibom
    Division of Medical Oncology and Transplantation, Duke University Medical Center, Durham, NC 27710, USA
    Clin Lymphoma 4:115-8. 2003
    ..5 months after completion of chlorambucil or radiation therapy (range, 3-25 months). Further follow-up is warranted to evaluate response duration and late toxicity of this novel treatment strategy..
  12. ncbi Molecular and cytogenetic characterization of a novel translocation t(4;22) involving the breakpoint cluster region and platelet-derived growth factor receptor-alpha genes in a patient with atypical chronic myeloid leukemia
    Anne Michele Safley
    Duke University School of Medicine, Durham, NC 27710, USA
    Genes Chromosomes Cancer 40:44-50. 2004
    ..Here, we report the molecular and cytogenetic characterization of a patient with BCR-PDGFRA-positive MPD who had a complete hematologic response after treatment with imatinib mesylate...
  13. ncbi Fine-needle aspiration in non-Hodgkin lymphoma: evaluation of cell size by cytomorphology and flow cytometry
    Jerald Z Gong
    Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA
    Am J Clin Pathol 117:880-8. 2002
    ..Surgical biopsy is necessary when there is necrosis, fewer than 10% neoplastic cells by FC, or fewer than 40% large cells with clinical signs of transformation...
  14. ncbi Myelodysplasia as masquerader: A woman with hypereosinophilic syndrome and twelve years of "chronic ITP"
    Corinne M Linardic
    Department of Pediatrics, Division of Hematology-Oncology, Duke University Medical Center, Durham, North Carolina 27710, USA
    Med Pediatr Oncol 39:137-8. 2002
  15. ncbi Lack of circulating megakaryoblasts in newborn peripheral blood: development and validation of a sensitive flow cytometric detection method
    Sherry Bayliff
    Department of Pediatrics, University of Kentucky School of Medicine, Lexington, KY 40536 0284, USA
    J Pediatr Hematol Oncol 25:721-5. 2003
    ..Less than 1% of circulating nucleated cells in the blood of newborn infants are megakaryoblasts, providing a comparison population for the authors' larger proposed incidence study...
  16. ncbi Primary autoimmune myelofibrosis: definition of a distinct clinicopathologic syndrome
    Vinod Pullarkat
    Division of Hematology, Keck School of Medicine, University of Southern California, Los Angeles, California 91010 300, USA
    Am J Hematol 72:8-12. 2003
    ..Primary AIMF appears to have an excellent prognosis, with all patients reported in this series responding to a short course of corticosteroid therapy...
  17. ncbi NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors
    Roberto Chiarle
    Department of Pathology and Kaplan Comprehensive Cancer Center, and Department of Pediatric Oncology, New York University School of Medicine, New York, NY 10016, USA
    Blood 101:1919-27. 2003
    ..Our NPM-ALK Tg mice are a suitable model to dissect the molecular mechanisms of ALK-mediated transformation and to investigate the efficacy of new therapeutic approaches for the treatment of human ALCL in vivo...